April 9, 2024
View Full PaperNon-motor Effects of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study (P9-3.001)
Key Points
Key points are not available for this paper at this time.
Abstract
Explore the impact of bemdaneprocel on non-motor symptoms in participants with Parkinson's disease.